Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors
<p>Abstract</p> <p>Background</p> <p>Kidney disease is an important complication in HIV infected people, and this may be related to infection or antiretroviral therapy (ART). Our aim is to assess renal function in HIV infected paediatric patients, who may be particularl...
Main Authors: | Pontrelli Giuseppe, Cotugno Nicola, Amodio Donato, Zangari Paola, Tchidjou Hyppolite K, Baldassari Stefania, Palma Paolo, Bernardi Stefania |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-01-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/12/18 |
Similar Items
-
A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate versus Tenofovir Alafenamide
by: Chanie Wassner PharmD, BCCCP, BCIDP, et al.
Published: (2020-04-01) -
Liquid chromatography metabolite profiling of tenofovir disoproxil fumarate
by: Kokil Sachin, et al.
Published: (2009-01-01) -
The genotoxicity of Tenofovir disoproxil fumarate in HBV-infected patients
by: Selcen Korkmaz, et al.
Published: (2018-09-01) -
Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide
by: Sarah M Michienzi, et al.
Published: (2021-07-01) -
Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide
by: Nicholas T. Funderburg, et al.
Published: (2016-11-01)